Invention Grant
- Patent Title: Antibodies useful in cancer diagnosis
-
Application No.: US17666122Application Date: 2022-02-07
-
Publication No.: US11919951B2Publication Date: 2024-03-05
- Inventor: Rita Mitnacht-Kraus , Stefan Wöll , Korden Walter , Özlem Türeci , Ugur Sahin
- Applicant: Astellas Pharma Inc. , TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz GmbH
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.,TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Current Assignee: Astellas Pharma Inc.,TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Current Assignee Address: JP Tokyo; DE Mainz
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; G01N33/50 ; C12N5/09 ; C12Q1/6886 ; A61K47/68 ; G01N33/574
Abstract:
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN6 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN6.
Public/Granted literature
- US20220162302A1 ANTIBODIES USEFUL IN CANCER DIAGNOSIS Public/Granted day:2022-05-26
Information query
